Most recent by John DeRosier
Combination reduces relapse incidence after allogeneic HSCT in high-risk AML subset
Recombinant human granulocyte colony-stimulating factor combined with minimal-dose decitabine appeared to reduce relapse incidence after allogeneic transplant among patients with high-risk acute myeloid leukemia, study results showed.
Genomic alterations may be linked to higher prostate cancer mortality among Black men
Black men with prostate cancer appeared to have a higher frequency of genetic alterations that may contribute to aggressive disease compared with their white counterparts, according to study results published in Molecular Cancer Research.
HCC mortality higher for patients from rural areas, lower-income households
Patients with hepatocellular carcinoma who live in rural regions or lower-income households had more advanced disease at diagnosis and higher disease-related mortality than other patients, according to study results published in Cancer.
Bone mineral density testing rates still low among men receiving ADT for prostate cancer
Rates of bone mineral density testing among men with prostate cancer undergoing androgen deprivation therapy have risen since 2000 but remain low, according to study results published in Journal of the National Comprehensive Cancer Network.
Cancer led to 4 million potential years of life lost in 2017
Cancer led to 4 million potential years of life lost in 2017 in the United States, with cancers occurring in younger patients accounting for a disproportionate amount of the burden, according to study results.
Web-based app can help weigh impact of cancer treatment delays during COVID-19 pandemic
A new web-based application can help estimate the impact of treatment delays for individual patients with cancer and optimize allocation of resources during the COVID-19 pandemic, according to results of a study published in JAMA Oncology.
Hydroxyurea before puberty may not affect spermatogenesis in boys with sickle cell disease
Toxicity on spermatogenesis may not be a major concern for boys with severe sickle cell disease who require hydroxyurea treatment before puberty, according to results of a study published in Blood.
Diagnostic radiation below the waist may increase risk for testicular cancer
Exposure to diagnostic radiation below the waist may increase risk for testicular germ cell tumors, according to results of a case-control study published in PLOS One.
Strategies aim to ensure cancer care for Americans ‘without financial ruin’
The cost of cancer care in the U.S. continues to rise as debate persists about how to best bring down drug prices while ensuring sufficient health care coverage.
Pembrolizumab plus chemotherapy effective in newly diagnosed classical Hodgkin lymphoma
Pembrolizumab followed by doxorubicin, vinblastine and dacarbazine appeared safe and effective for newly diagnosed classical Hodgkin lymphoma, including for patients with bulky disease, according to phase 2 study results published in Blood.